Here are four things to know:
1. The market is projected to grow at a compound annual growth rate of 3.6 percent, increasing its value from the $562 million it was worth in 2015 to $724 million by 2022.
2. Market drivers are expected to include the increase in geriatric population and the rise of osteoporosis and arthritis.
3. Market impeders may be the high initial cost of stimulators as well as the advent of bone growth-stimulating drugs, fixation instrumentation during fusion and non-fusion fractures.
4. Bone stimulators deliver low-voltage electrical currents to the spinal area where spine fusion is expected to occur.
More articles on devices:
Baxter highlights FLOSEAL hemostatic agent enhancements for spine, cardiac surgery: 5 highlights
Implanet intends to transfer share listing from Euronext to Alternext Paris: 5 key notes
Spinal implant 3D printing: 5 findings from 2 key cases
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
